David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Enpro
NPO
$6.4B
| $674K | ﹤0.01% |
7,896
-9,115
| -54% | -$744K |
|
3227
Rhythm Pharmaceuticals
RYTM
$7.78B
| $673K | ﹤0.01% |
+31,653
| New | +$918K |
|
3228
AZZ Inc
AZZ
$4.17B
| $672K | ﹤0.01% |
13,339
-5,380
| -29% | -$272K |
|
3229
Innospec
IOSP
$2.32B
| $672K | ﹤0.01% |
6,547
-11,556
| -64% | -$1.14M |
|
3230
Columbia Financial
CLBK
$1.22B
| $668K | ﹤0.01% |
+38,197
| New | +$634K |
|
3231
Westwood Holdings Group
WHG
$186M
| $667K | ﹤0.01% |
46,099
-9,054
| -16% | -$139K |
|
|
ALLK
3232
CALL
DELISTED
Allakos
ALLK
| $666K | ﹤0.01% |
5,800
-10,000
| -63% | -$1.26M |
|
3233
State Street Technology Select Sector SPDR ETF
XLK
$118B
| $664K | ﹤0.01% |
+10,000
| New | +$660K |
|
3234
PUT
Arrowhead Research
ARWR
$12.5B
| $663K | ﹤0.01% |
10,000
| – | – |
|
3235
PUT
Under Armour
UAA
$2.22B
| $663K | ﹤0.01% |
29,900
-170,100
| -85% | -$3.55M |
|
|
CADE
3236
DELISTED
Cadence Bancorporation
CADE
| $662K | ﹤0.01% |
+31,944
| New | +$650K |
|
|
ELVT
3237
DELISTED
Elevate Credit, Inc.
ELVT
| $659K | ﹤0.01% |
225,834
-54,732
| -20% | -$228K |
|
3238
Dorian LPG
LPG
$2.16B
| $658K | ﹤0.01% |
+50,151
| New | +$666K |
|
3239
Astec Industries
ASTE
$1.01B
| $655K | ﹤0.01% |
8,687
-5,885
| -40% | -$399K |
|
3240
Jacobs Solutions
J
$17.6B
| $655K | ﹤0.01% |
6,127
-13,759
| -69% | -$1.31M |
|
3241
Illinois Tool Works
ITW
$80.3B
| $652K | ﹤0.01% |
2,944
-261,582
| -99% | -$54.3M |
|
3242
HBT Financial
HBT
$1.29B
| $647K | ﹤0.01% |
37,755
-3,913
| -9% | -$63.5K |
|
|
OCAXU
3243
DELISTED
OCA Acquisition Corp. Unit
OCAXU
| $645K | ﹤0.01% |
+64,568
| New | +$663K |
|
3244
Brady Corp
BRC
$4.38B
| $644K | ﹤0.01% |
12,043
-40,578
| -77% | -$2.12M |
|
|
ENJY
3245
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $641K | ﹤0.01% |
+64,835
| New | +$669K |
|
3246
Pan American Silver
PAAS
$22.4B
| $639K | ﹤0.01% |
21,285
-58,889
| -73% | -$1.91M |
|
|
BERY
3247
DELISTED
Berry Global Group, Inc.
BERY
| $639K | ﹤0.01% |
+11,333
| New | +$588K |
|
|
WPRT
3248
Westport Fuel Systems
WPRT
$34.8M
| $638K | ﹤0.01% |
+8,860
| New | +$749K |
|
3249
AGCO
AGCO
$7.75B
| $635K | ﹤0.01% |
4,417
-84,380
| -95% | -$10.5M |
|
3250
Cabot Corp
CBT
$4.31B
| $635K | ﹤0.01% |
12,109
-28,466
| -70% | -$1.4M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.